The Healthcare+ Expo Taiwan Continues to Lead a Medical Innovation Hub With Its Strength in Digital Health, Health Tech and Medicine
30.7.2019 16:05:00 EEST | Business Wire | Press release
Following the success last year, the Healthcare+ Expo sees a rapid growth in size and significance of procurement, networking and marketing. The Expo is now regarded as a primary event in Asia, attracting global participation from more than 5,000 buyers, 500 enterprises, 60 high-profile speakers and 100 professional institutions to come to Taipei on 5-8 December 2019.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190730005084/en/
Where key opinion leaders go and business grows
Exhibitors this year have a strong presence in medical AI, health tech and medicine. World-class medical centres, IT giants, international brands for medical devices and innovative startups congregate at the Expo to impress audiences with advanced health tech and life-saving medical development. In addition to that, the Expo sets the theme to digital health utilising AI, IoT, cloud computing and robotics, new technology for cancer treatment, precision health and smart hospitals in response to robust market demands.
As part of the Expo programmes, MEDTEX Summit Asia brings together 10 top venture capital firms, global AI pioneers, a Nobel Prize winner and multinational pharmaceutical executives to project their views on futuristic trends of healthcare. Visitors having business agendas can then anticipate fruitful results gained in conferences, match-making sessions and roadshows, as well as taking home with high quality market insights.
Why Taiwan matters to healthcare industry
Taiwan has a competitive edge as it is situated the heart of Asia, with proximity and commercial links to emerging economics, and a home to leading electronics manufacturers and well-connected supply chains. Coupling with its strength in tech, the healthcare system here provides not only a universal coverage for every citizen but a massive amount of data collected over years that paves the way for Taiwan to excel in wider healthcare business competitions.
The Expo thus invites those who are or will be in healthcare business, to save the date, come prepared and stay connected wherever they are. Visitors with interest in the Expo are suggested booking a place online beforehand (click here); early bird offers are available now until 30 September.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190730005084/en/
Contact information
Research Centre for Biotechnology and Medicine Policy
Gordon Shen PhD. +886 2 2655 7888 Ext.630 chinhuishen@rbmp.org.tw
Miss Silvia Fan +886 2 2655 7888 Ext.649 silvia@rbmp.org.tw
David Yang PhD. +886 2 2655 7888 Ext.627 fmyang@rbmp.org.tw
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The smarter E Europe: The Special Exhibit Renewables 24/7 Shows How a Renewable Energy Supply Is Possible21.4.2026 14:00:00 EEST | Press release
The current geopolitical situation once again highlights the risks of depending on fossil fuels and the increasing need to transform our energy supply. Solar and wind power have long been established as cost-efficient energy sources, and the International Energy Agency (IEA) has predicted a global 2.6-fold capacity growth between 2022 and 2030. Against this backdrop, The smarter E Europe alliance of exhibitions will spotlight the feasibility of a renewable energy system from June 23–25 in Munich. The Special Exhibit Renewables 24/7 uses best practices, presentations and live demos to show how a round-the-clock renewable energy supply can be achieved. To kick off the exhibition on June 23, The smarter E Europe will present an exclusive accompanying study, conducted in collaboration with the Fraunhofer Institute for Solar Energy Systems, that dispels common myths about system stability and provides scientific proof that such an energy system is viable. The study, Pathways to a Renewable
The smarter E Europe: The Special Exhibit Renewables 24/7 Shows How a Renewable Energy Supply Is Possible21.4.2026 14:00:00 EEST | Press release
The current geopolitical situation once again highlights the risks of depending on fossil fuels and the increasing need to transform our energy supply. Solar and wind power have long been established as cost-efficient energy sources, and the International Energy Agency (IEA) has predicted a global 2.6-fold capacity growth between 2022 and 2030. Against this backdrop, The smarter E Europe alliance of exhibitions will spotlight the feasibility of a renewable energy system from June 23–25 in Munich. The Special Exhibit Renewables 24/7 uses best practices, presentations and live demos to show how a round-the-clock renewable energy supply can be achieved. To kick off the exhibition on June 23, The smarter E Europe will present an exclusive accompanying study, conducted in collaboration with the Fraunhofer Institute for Solar Energy Systems, that dispels common myths about system stability and provides scientific proof that such an energy system is viable. The study, Pathways to a Renewable
Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments21.4.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it has entered into a collaboration with Osmind, the platform powering a nationwide network of interventional psychiatry practices. This collaboration will inform how small-to-medium sized clinics nationwide can effectively deliver novel psychedelic treatments, if FDA approved. The agreement with Osmind further expands the set of collaborations that Compass has established to inform the potential delivery of COMP360 in a broad spectrum of settings where people living with mental health conditions receive their care in the United States. Osmind is a public benefit corporation advancing psychiatry through technology, services, and real-world evidence to bring innovative mental health treatments to patients in need. Osmind’s network of over 1,000 clinics comprises one of the country’s largest network of interventional psychiatry practices. Its
Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments21.4.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it has entered into a collaboration with Osmind, the platform powering a nationwide network of interventional psychiatry practices. This collaboration will inform how small-to-medium sized clinics nationwide can effectively deliver novel psychedelic treatments, if FDA approved. The agreement with Osmind further expands the set of collaborations that Compass has established to inform the potential delivery of COMP360 in a broad spectrum of settings where people living with mental health conditions receive their care in the United States. Osmind is a public benefit corporation advancing psychiatry through technology, services, and real-world evidence to bring innovative mental health treatments to patients in need. Osmind’s network of over 1,000 clinics comprises one of the country’s largest network of interventional psychiatry practices. Its
Aventon Expands B2B Payment Terms Program to Germany with TreviPay21.4.2026 12:00:00 EEST | Press release
TreviPay, a global B2B payments infrastructure partner, today announced the expansion of its partnership with Aventon to support the launch of the Aventon Payment Terms program in Germany. Building on the success of Aventon’s existing program in the US and Canada, the new offering will give qualified B2B buyers in Germany access to invoicing and flexible payment terms designed to make purchasing easier and more predictable. As Aventon enters the German market and expands its presence in Europe, TreviPay will serve as the exclusive provider of payment terms for Aventon’s B2B buyers. The program is designed to help Aventon’s retail partners buy more confidently and manage working capital more effectively, while supporting the brand’s long-term growth in a new geography. By offering trade credit through TreviPay, Aventon can give retailers greater purchasing flexibility and strengthen its ability to compete in a dynamic market. TreviPay research shows 78% of B2B buyers say offering invoic
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom